{"id":"https://openalex.org/W60352094","doi":null,"title":"An Innovative Phase I Trial Design Allowing for the Identification of Multiple Potential Maximum Tolerated Doses with Combination Therapy of Targeted Agents","display_name":"An Innovative Phase I Trial Design Allowing for the Identification of Multiple Potential Maximum Tolerated Doses with Combination Therapy of Targeted Agents","alternate_titles":[],"publication_year":2010,"publication_date":"2010-01-01","ids":{"openalex":"https://openalex.org/W60352094","mag":"60352094"},"language":"en","primary_location":{"id":"pmh:oai:digitalcommons.library.tmc.edu:utgsbs_dissertations-1089","doi":null,"is_oa":true,"landing_page_url":"https://digitalcommons.library.tmc.edu/utgsbs_dissertations/72","pdf_url":"https://digitalcommons.library.tmc.edu/context/utgsbs_dissertations/article/1089/viewcontent/Thesis_08_13_2010.pdf","source":{"id":"https://openalex.org/S4377196655","display_name":"Digital Commons-TMC (Texas Medical Center)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1337852284","host_organization_name":"Texas Medical Center","host_organization_lineage":["https://openalex.org/I1337852284"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Dissertations & Theses (Open Access)","raw_type":"text"},"parent_works":[],"lineage":["https://openalex.org/W60352094"],"child_works_count":0,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://digitalcommons.library.tmc.edu/context/utgsbs_dissertations/article/1089/viewcontent/Thesis_08_13_2010.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026538331","display_name":"Sarina Anne Piha-Paul","orcid":"https://orcid.org/0000-0001-9455-1660","observed_orcids":["https://orcid.org/0000-0001-9455-1660"]},"institutions":[{"id":"https://openalex.org/I919571938","display_name":"The University of Texas Health Science Center at Houston","ror":"https://ror.org/03gds6c39","country_code":"US","type":"education","lineage":["https://openalex.org/I919571938"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Sarina A. Piha\u2010Paul","raw_affiliation_strings":["Graduate School of Biomedical Sciences, The University of Texas Health Science Center of Houston"],"raw_orcid":"https://orcid.org/0000-0001-9455-1660","affiliations":[{"raw_affiliation_string":"Graduate School of Biomedical Sciences, The University of Texas Health Science Center of Houston","institution_ids":["https://openalex.org/I919571938"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5026538331"],"corresponding_institution_ids":["https://openalex.org/I919571938"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11798","display_name":"Optimal Experimental Design Methods","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1803","display_name":"Management Science and Operations Research"},"field":{"id":"https://openalex.org/fields/18","display_name":"Decision Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/phase-i-trial-design","display_name":"phase I trial design","score":0.8960000276565552},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.9539999961853027},{"id":"https://openalex.org/keywords/molecularly-targeted-agents","display_name":"molecularly targeted agents","score":0.6549999713897705},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8460000157356262},{"id":"https://openalex.org/keywords/temsirolimus","display_name":"temsirolimus","score":0.8690000176429749},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":1.0},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.7400000095367432},{"id":"https://openalex.org/keywords/hif-1alpha","display_name":"HIF-1\u03b1","score":0.8339999914169312},{"id":"https://openalex.org/keywords/vegf-signaling-pathway","display_name":"VEGF pathway","score":0.7910000085830688},{"id":"https://openalex.org/keywords/dose-selection","display_name":"dose selection","score":0.4339999854564667},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.3799999952316284},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.3059999942779541},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.4000000059604645},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.47600001096725464},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-related-pneumonitis","display_name":"immune-related pneumonitis","score":0.3799999952316284}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7016497850418091},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6816373467445374},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.6584320664405823},{"id":"https://openalex.org/C2777334693","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Maximum tolerated dose","level":3,"score":0.5869222283363342},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5374866724014282},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5045222043991089},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.45161038637161255},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.38372859358787537},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26286569237709045}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:digitalcommons.library.tmc.edu:utgsbs_dissertations-1089","doi":null,"is_oa":true,"landing_page_url":"https://digitalcommons.library.tmc.edu/utgsbs_dissertations/72","pdf_url":"https://digitalcommons.library.tmc.edu/context/utgsbs_dissertations/article/1089/viewcontent/Thesis_08_13_2010.pdf","source":{"id":"https://openalex.org/S4377196655","display_name":"Digital Commons-TMC (Texas Medical Center)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1337852284","host_organization_name":"Texas Medical Center","host_organization_lineage":["https://openalex.org/I1337852284"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Dissertations & Theses (Open Access)","raw_type":"text"},{"id":"mag:60352094","doi":null,"is_oa":false,"landing_page_url":"https://digitalcommons.library.tmc.edu/utgsbs_dissertations/72/","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"pmh:oai:digitalcommons.library.tmc.edu:utgsbs_dissertations-1089","doi":null,"is_oa":true,"landing_page_url":"https://digitalcommons.library.tmc.edu/utgsbs_dissertations/72","pdf_url":"https://digitalcommons.library.tmc.edu/context/utgsbs_dissertations/article/1089/viewcontent/Thesis_08_13_2010.pdf","source":{"id":"https://openalex.org/S4377196655","display_name":"Digital Commons-TMC (Texas Medical Center)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1337852284","host_organization_name":"Texas Medical Center","host_organization_lineage":["https://openalex.org/I1337852284"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Dissertations & Theses (Open Access)","raw_type":"text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W60352094.pdf","grobid_xml":"https://content.openalex.org/works/W60352094.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W169489141","https://openalex.org/W607442839","https://openalex.org/W1830307401","https://openalex.org/W1857731992","https://openalex.org/W1970939192","https://openalex.org/W1972739162","https://openalex.org/W1977267072","https://openalex.org/W1978139448","https://openalex.org/W1988581394","https://openalex.org/W1992116006","https://openalex.org/W1994001783","https://openalex.org/W1996811911","https://openalex.org/W1999966784","https://openalex.org/W2006862074","https://openalex.org/W2013041233","https://openalex.org/W2038440449","https://openalex.org/W2073495273","https://openalex.org/W2074054907","https://openalex.org/W2074824347","https://openalex.org/W2080237506","https://openalex.org/W2081633887","https://openalex.org/W2084740377","https://openalex.org/W2087568114","https://openalex.org/W2094794021","https://openalex.org/W2095103739","https://openalex.org/W2100945863","https://openalex.org/W2117263216","https://openalex.org/W2130219349","https://openalex.org/W2137090229","https://openalex.org/W2139248078","https://openalex.org/W2139819066","https://openalex.org/W2153867442","https://openalex.org/W2166573361","https://openalex.org/W4233892758"],"related_works":["https://openalex.org/W1989847233","https://openalex.org/W1857731992","https://openalex.org/W2046235081","https://openalex.org/W2148984221","https://openalex.org/W2103789651","https://openalex.org/W6902106727","https://openalex.org/W4241214143","https://openalex.org/W4416871545","https://openalex.org/W2590918077","https://openalex.org/W805622244"],"abstract_inverted_index":{"Treatment":[0],"for":[1,21,119,208,223,290,339,370,391,495],"cancer":[2],"often":[3,418],"involves":[4],"combination":[5,62,73,87,107,329,352],"therapies":[6],"used":[7,71],"both":[8,227],"in":[9,72,106,128,265,320,351,355,360,415,500],"medical":[10],"practice":[11],"and":[12,16,38,83,220,272,293,343,441,451,479],"clinical":[13,90],"trials.":[14],"Korn":[15],"Simon":[17],"listed":[18],"three":[19],"reasons":[20],"the":[22,49,53,65,69,95,140,150,154,255,280,404,425,481,505],"utility":[23],"of":[24,32,56,59,68,97,104,159,197,203,211,217,226,248,257,297,305,323,347,388,406,428,433,445,455,470,483],"combinations:":[25],"1)":[26],"biochemical":[27],"synergism,":[28],"2)":[29],"differential":[30],"susceptibility":[31],"tumor":[33,291,298],"cells":[34],"to":[35,48,138,300,314],"different":[36,115],"agents,":[37,174,412],"3)":[39],"higher":[40],"achievable":[41],"dose":[42,143,151,155,345,389,395,427,435,443,453,501],"intensity":[43],"by":[44,384],"exploiting":[45],"non-overlapping":[46],"toxicities":[47],"host.":[50],"Even":[51],"if":[52,475],"toxicity":[54,66,165],"profile":[55,67],"each":[57,392],"agent":[58],"a":[60,98,102,109,120,129,258,276,335,356,484,496,513],"given":[61,350,414],"is":[63,79,92,113,137,147,240,275,288,303],"known,":[64],"agents":[70],"must":[74],"be":[75,190,458,510],"established.":[76],"Thus,":[77],"caution":[78],"required":[80],"when":[81,413],"designing":[82],"evaluating":[84,340],"trials":[85,170,409],"with":[86,200,214,447],"therapies.":[88],"Traditional":[89],"design":[91,245,337,375,382,466],"based":[93,511],"on":[94],"consideration":[96],"single":[99,259,485],"drug.":[100,393],"However,":[101],"trial":[103,135,235,244,269,336,374,465],"drugs":[105,125,228,263,349],"requires":[108],"dose-selection":[110],"procedure":[111],"that":[112,117,171,193,410,462,508],"vastly":[114],"than":[116,176,250,424,472],"needed":[118],"single-drug":[121],"trial.":[122],"When":[123],"two":[124,158,173,262,348],"are":[126,183,270,397,417],"combined":[127,264],"phase":[130,168,233,267,407],"I":[131,169,234,268,408],"trial,":[132],"an":[133,191,327],"important":[134],"objective":[136],"determine":[139],"maximum":[141],"tolerated":[142],"(MTD).":[144],"The":[145,261],"MTD":[146,178,192,239,252],"defined":[148],"as":[149,353],"level":[152],"below":[153],"at":[156,420],"which":[157,287,311],"six":[160],"patients":[161],"experience":[162,405],"drug-related":[163],"dose-limiting":[164],"(DLT).":[166],"In":[167],"combine":[172],"more":[175,249,471,497],"one":[177,207,238,251,473],"generally":[179],"exists,":[180],"although":[181],"all":[182],"rarely":[184],"determined.":[185],"For":[186],"example,":[187],"there":[188],"may":[189],"includes":[194],"high":[195,209,344],"doses":[196,202,210,216,225],"drug":[198,204,212,218],"A":[199,431],"lower":[201,215,423],"B,":[205],"another":[206,222],"B":[213],"A,":[219],"yet":[221],"intermediate":[224,342,440],"administered":[229],"together.":[230],"With":[231],"classic":[232],"designs,":[236],"only":[237],"identified.":[241],"Our":[242],"new":[243,464],"allows":[246],"identification":[247,469],"efficiently,":[253],"within":[254,480],"context":[256,482],"protocol.":[260,486],"our":[266,463],"temsirolimus":[271,446],"bevacizumab.":[273],"Bevacizumab":[274],"monoclonal":[277],"antibody":[278],"targeting":[279],"vascular":[281],"endothelial":[282],"growth":[283,292],"factor":[284,308],"(VEGF)":[285],"pathway":[286],"fundamental":[289],"metastasis.":[294],"One":[295],"mechanism":[296],"resistance":[299],"antiangiogenic":[301],"therapy":[302],"upregulation":[304],"hypoxia":[306],"inducible":[307],"1\u03b1":[309],"(HIF-1\u03b1)":[310],"mediates":[312],"responses":[313],"hypoxic":[315],"conditions.":[316],"Temsirolimus":[317],"has":[318,402],"resulted":[319],"reduced":[321],"levels":[322,346,390,396,422,436,444,454],"HIF-1\u03b1":[324],"making":[325],"this":[326,381,490],"ideal":[328],"therapy.":[330],"Dr.":[331],"Donald":[332],"Berry":[333],"developed":[334],"schema":[338,383],"low,":[341],"illustrated":[354],"recently":[357],"published":[358],"paper":[359],"Biometrics":[361],"entitled":[362],"\u201cA":[363],"Parallel":[364],"Phase":[365],"I/II":[366],"Clinical":[367],"Trial":[368],"Design":[369],"Combination":[371],"Therapies.\u201d":[372],"His":[373],"utilized":[376],"cytotoxic":[377],"chemotherapy.":[378],"We":[379,460],"adapted":[380],"incorporating":[385],"greater":[386],"numbers":[387],"Additional":[394],"being":[398],"examined":[399],"because":[400],"it":[401],"been":[403],"targeted":[411],"combination,":[416],"effective":[419],"dosing":[421],"FDA-approved":[426],"said":[429],"drugs.":[430],"total":[432],"thirteen":[434],"including":[437],"representative":[438,448],"high,":[439,449],"low":[442,452],"intermediate,":[450],"bevacizumab":[456],"will":[457,467],"evaluated.":[459],"hypothesize":[461],"facilitate":[468],"MTD,":[474],"they":[476],"exist,":[477],"efficiently":[478],"Doses":[487],"gleaned":[488],"from":[489,503],"approach":[491,499],"could":[492],"potentially":[493],"allow":[494],"personalized":[498],"selection":[502],"among":[504],"MTDs":[506],"obtained":[507],"can":[509],"upon":[512],"patient\u2019s":[514],"specific":[515],"co-morbid":[516],"conditions":[517],"or":[518],"anticipated":[519],"toxicities.":[520]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W60352094","counts_by_year":[{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
